SCHEMBL7884243

SCHEMBL7884243

CNC(N)=NC(=O)c1cc2ccc(Oc3cccc(CN(C)C)c3)cc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
ROCK2 O75116 4/20 0.41
ROCK1 Q13464 4/20 0.41
PPARG P37231 2/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
PTGES O14684 1/20 0.38
XDH P47989 1/20 0.37
NOS1 P29475 1/20 0.37
PARP1 P09874 1/20 0.37
ACHE P22303 1/20 0.36
FLT3 P36888 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873340 0.92 KMT2A (0.43) MEN1KMT2ARXFP1NPC1RAB9A
SCHEMBL7877501 0.89 KMT2A (0.41) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7877814 0.89 KMT2A (0.39) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7877892 0.89 FLT3 (0.45) MEN1KMT2ARXFP1NPC1RAB9A
SCHEMBL7881485 0.86 PPARG (0.39) PPARGPPARDPPARAF2F10
SCHEMBL7884570 0.85 MEN1 (0.38) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7882069 0.85 XDH (0.51) MEN1KMT2ARXFP1NPC1RAB9A
SCHEMBL7882184 0.85 RHEB (0.35) ROCK2PPARGPPARDPPARAF2
SCHEMBL7877734 0.85 FLT3 (0.46) MEN1KMT2ARXFP1NOS1ACHE
SCHEMBL7881191 0.84 KMT2A (0.39) MEN1KMT2ARXFP1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed